BeOne Medicines AG

BEIGF ·Healthcare, Drug Manufacturers - General
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015
Assets
Cash & Equivalents $239.6M $87.5M $17.9M
Accounts Receivable $29.4M — —
Inventory $10.9M — —
Total Current Assets $913.5M $374.4M $106.3M
Property, Plant & Equipment $62.6M $26.0M $6.6M
Goodwill $109.0K — —
Intangible Assets (Excl. Goodwill) $7.3M — —
Total Assets $1.05B $405.8M $116.8M
Liabilities
Accounts Payable $69.8M $12.0M $9.0M
Total Current Liabilities $150.0M $35.1M $35.2M
Long-Term Debt $9.2M $17.3M —
Total Liabilities $362.2M $52.9M $42.4M
Stockholders' Equity
Retained Earnings $-330.5M $-237.4M $-118.2M
Total Stockholders' Equity $669.8M $352.9M $-101.8M
← Newer Page 2 of 2 Older →